New drug shows promise in reversing memory loss for early Alzheimer's patients. ScienceDaily . Retrieved February 27, 2025 from www.sciencedaily.com / releases / 2025 / 02 / 250204141840.htm ...

Ms. Jinhua Zhang, Founder, Chairwoman, and CEO of IASO Bio, stated: "We are delighted that the New Drug Application for Equecabtagene Autoleucel has been officially accepted by the Hong Kong ...

The new drug combination reduced the risk of disease progression or death by 27%, with patients on the Calquence combination living an average of 66.4 months without their cancer getting worse ...

Ms. Jinhua Zhang, Founder, Chairwoman, and CEO of IASO Bio, stated: "We are delighted that the New Drug Application for Equecabtagene Autoleucel has been officially accepted by the Hong Kong ...

The FDA requested new and updated information and clarifications related to drug substance, drug product, manufacturing, and microbiology. The FDA did not express concern about the stability of the ...

The Union Public Service Commission (UPSC) will allow the candidates registering for the Civil Services (Preliminary) Examination 2025 and Indian Foreign Service (Preliminary) Examinations 2025 to ...

Eton Pharmaceuticals, Inc. announced that the FDA has extended the PDUFA goal date for its New Drug Application (NDA) for ET-400 to May 28, 2025, allowing the agency additional time to review ...

According to Lambert, the wound dressings are on track for regulatory submission as medical devices, which, if approved, offers a faster pathway to market compared to new drug applications.

under which applications and appeals against rejected applications submitted before the new rules come into force should be judged under the current rules. This was in order to safeguard individual ...

The new treatment targets inflammation directly within the joints so that therapeutic agents are released only when needed. The approach is different from traditional treatments that often rely on ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, published Jan. 29 in Nature Communications, reveals a new signaling ...

The company (NOVOb.CO), opens new tab remains "quite encouraged" by the data which clearly shows better weight-loss than the company's blockbuster obesity drug Wegovy, Martin Holst Lange ...